Abstract:Mechanisms restricting local inflammation and preventing systemic spreading of diseases are hardly understood. Release of S100A8/S100A9‐dimers at local sites of inflammation leads to monocyte activation via TLR4 while calcium‐induced S100A8/S100A9‐tetramer formation in the extracellular space mitigates monocyte dynamics via CD69. Thus, different quaternary structures of the same molecules promote inflammation locally (S100‐dimer/TLR4) but simultaneously protect systemic spreading of inflammation (S100‐tetramer/CD69). Mechanisms keeping leukocytes distant of local inflammatory processes in a resting state despite systemic release of inflammatory triggers are a pivotal requirement for avoidance of overwhelming inflammation but are ill defined. Dimers of the alarmin S100A8/S100A9 activate Toll‐like receptor‐4 (TLR4) but extracellular calcium concentrations induce S100A8/S100A9‐tetramers preventing TLR4‐binding and limiting their inflammatory activity. So far, only antimicrobial functions of released S100A8/S100A9‐tetramers (calprotectin) are described. It is demonstrated that extracellular S100A8/S100A9 tetramers significantly dampen monocyte dynamics as adhesion, migration, and traction force generation in vitro and immigration of monocytes in a cutaneous granuloma model and inflammatory activity in a model of irritant contact dermatitis in vivo. Interestingly, these effects are not mediated by the well‐known binding of S100A8/S100A9‐dimers to TLR‐4 but specifically mediated by S100A8/S100A9‐tetramer interaction with CD69. Thus, the quaternary structure of these S100‐proteins determines distinct and even antagonistic effects mediated by different receptors. As S100A8/S100A9 are released primarily as dimers and subsequently associate to tetramers in the high extracellular calcium milieu, the same molecules promote inflammation locally (S100‐dimer/TLR4) but simultaneously protect the wider environment from overwhelming inflammation (S100‐tetramer/CD69).

S100A8/A9: From basic science to clinical application

S100A8/A9 in Inflammation

Inflammatory role of S100A8/A9 in the central nervous system non-neoplastic diseases

S100A8 and S100A9 in Cancer

The functions and regulatory pathways of S100A8/A9 and its receptors in cancers

S100a8/A9 proteins: critical regulators of inflammation in cardiovascular diseases

Cytosolic S100A8/A9 promotes Ca supply at LFA-1 adhesion clusters during neutrophil recruitment

Roles of S100A8, S100A9 and S100A12 in infection, inflammation and immunity

Alarming and Calming: Opposing Roles of S100A8/S100A9 Dimers and Tetramers on Monocytes

[S100A8/A9 and periodontal inflammatory diseases]

Research Progress of S100A8/A9 Protein in Rheumatoid Arthritis

S100A8/A9 (calprotectin) is critical for development of glomerulonephritis and promotes inflammatory leukocyte-renal cell interactions

S100A8/A9: An emerging player in sepsis and sepsis-induced organ injury

S100A7:Biological properties and implications in diseases

S100A proteins as molecular targets in the ocular surface inflammatory diseases

Unraveling the Mechanisms of S100A8/A9 in Myocardial Injury and Dysfunction

Computational Deciphering of the Role of S100A8 and S100A9 Proteins and Their Changes in the Structure Assembly Influences Their Interaction with TLR4, RAGE, and CD36

Transcriptional Profiling and Functional Analysis of N1/N2 Neutrophils Reveal an Immunomodulatory Effect of S100A9-Blockade on the Pro-Inflammatory N1 Subpopulation

Pathogenic Roles of Neutrophil‐derived Alarmins (S100A8/A9) in Heart Failure: from Molecular Mechanisms to Therapeutic Insights

S100 Proteins As an Important Regulator of Macrophage Inflammation

S100A8/S100A9 and their association with cartilage and bone